The Treasury Department (Treasury) and the Internal Revenue Service (IRS) released proposed tax regulations this week that will impact the biotech space dramatically around tax attributes (Net Operating Losses, R&D credits, etc.). These are “proposed” rules and there is a comment period, which we highly suggest BIO International and all state bio organizations contribute to the comment period. You may want to forward this to your policy folks and let RSM know if you need further explanation of these proposed regulations.
Proposed tax changes will impact biotech dramatically
Sep 11, 2019
Proposed rules on section 382 akin to a tax hike for many companies